Analyst Ratings for Regulus Therapeutics (RGLS)
RGLS Rating Summary
RGLS Price Target Summary
- Highest: $11.00 (Canaccord Genuity)
- Lowest: $3.00 (Wells Fargo)
- Average: $6.67
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$6.67 (+200.3%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 47%
Avg. $ Target:
$6.67 (+200.3%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 47%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/18/2024 | Leerink Partners | Joseph Schwartz | New Coverage | Outperform (N/A) |
6.00 (N/A) |
2.11 (2.22) |
5.21% | Details |
| 11/8/2022 | Canaccord Genuity » Updated 3/19/2024 |
Whitney Ijem | New Coverage | Buy (N/A) |
11.00 (12.00) |
1.46 (2.22) |
52.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
